You are here

Clinical Trials: Wounds and Injuries

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, August 4, 2020 - 12:00
Condition:   Diabetic Foot Ulcer
Intervention:   Biological: ALLO-ASC-SHEET
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting
Posted: Wednesday, July 22, 2020 - 12:00
Condition:   Severe COVID-19 Disease
Interventions:   Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19;   Other: Placebo
Sponsors:   Rapa Therapeutics LLC;   Hackensack Meridian Health
Not yet recruiting
Posted: Wednesday, June 24, 2020 - 12:00
Conditions:   COVID-19;   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting
Posted: Thursday, April 2, 2020 - 12:00
Conditions:   COVID-19;   Acute Respiratory Distress Syndrome;   Virus; Pneumonia;   Acute Lung Injury
Intervention:   Biological: CAStem
Sponsors:   Chinese Academy of Sciences;   Beijing YouAn Hospital
Recruiting
Posted: Friday, February 28, 2020 - 12:00
Condition:   Spinal Cord Injuries
Interventions:   Biological: Collection and expansion of BM-MSC;   Diagnostic Test: VI-SCI evaluation and patients' follow up
Sponsor:   University of Jordan
Recruiting
Posted: Friday, January 24, 2020 - 12:00
Condition:   Osteoarthritis, Knee
Interventions:   Biological: Catholic MASTER cell;   Other: Saline
Sponsor:   Seoul St. Mary's Hospital
Recruiting
Posted: Wednesday, January 22, 2020 - 12:00
Condition:   Objectively Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Chronic Wounds
Interventions:   Biological: Stem cell-derived derived pleiotropic factor;   Biological: fibroblast growth factor
Sponsor:   Chinese PLA General Hospital
Not yet recruiting
Posted: Monday, January 20, 2020 - 12:00
Condition:   Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites
Intervention:   Biological: mesenchymal stem cell conditioned medium-derived pleiotropic factor
Sponsor:   Chinese PLA General Hospital
Not yet recruiting
Posted: Monday, January 20, 2020 - 12:00
Condition:   the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound
Interventions:   Biological: epidermal growth factor;   Biological: mesenchymal stem cell conditioned medium-derived pleiotropic factor
Sponsor:   Chinese PLA General Hospital
Not yet recruiting
Posted: Thursday, December 19, 2019 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: Neuro-Cells
Sponsor:   Neuroplast
Not yet recruiting

Pages